Home/Filings/4/0001062993-23-001325
4//SEC Filing

GUIFFRE CHRISTOPHERD T 4

Accession 0001062993-23-001325

CIK 0001835567other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 4:07 PM ET

Size

5.3 KB

Accession

0001062993-23-001325

Insider Transaction Report

Form 4
Period: 2023-01-20
GUIFFRE CHRISTOPHERD T
CFO, COO, Treas., & Asst. Sec.
Transactions
  • Sale

    Class A Common Stock

    2023-01-20$1.13/sh19,540$22,08029,960 total
Footnotes (2)
  • [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $1.03 to $1.335, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.

Issuer

Pear Therapeutics, Inc.

CIK 0001835567

Entity typeother

Related Parties

1
  • filerCIK 0001219021

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:07 PM ET
Size
5.3 KB